Health on MSN3d
Medications That Could Interact With GLP-1sGLP-1s work by regulating the production of insulin and lowering your blood sugar. These medications also help treat obesity and aid in weight loss.
Objective: To review drug interaction studies of glucagon-like ... needed to further assess and allow comparison of several GLP-1RA agents' impact on steady-state pharmacokinetics and ...
Most patients may continue to safely take glucagon-like peptide-1 (GLP-1) receptor agonists as prescribed before undergoing ...
In a practice-changing guideline reversal, medical societies advised on Tuesday that most patients do not need to stop taking ...
Dr. John Sosa, a double board-certified expert in family and lifestyle medicine and the Chief Medical Officer for Drip Health ...
Less than a week after the U.S. Food & Drug Administration (FDA) determined that the shortage of the tirzepatide injection, a glucagon-like peptide ...
News Medical on MSN6d
Study: GLP-1RA not associated with acute kidney injury risk during anti-cancer treatmentsGlucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive heart failure. Reports of GLP-1RA–associated acute ...
Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...
Among 14,783 patients, 9% were treated with a GLP-1RA while taking ant-cancer drugs. AKI occurred in 7.2% of those exposed to GLP-1RA versus 6.4% of those with no GLP-1RA exposure. “Given the ...
Learn about GLP-1 medications, their benefits, risks, and who should (or shouldn’t) consider using them. Design elements: Getty Images. Collage: Cassie Basford. Reviewed by Dietitian Jessica ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback